Health Care · Pharmaceutical Preparations · Nasdaq · CIK 1430306 · FYE Dec 31 · Prices AT CLOSE 2026-08-19 (USD) Last $12.73 · Day +0.55% · Mkt cap $217M · 1Y −65.2% · Off 52W high −67.7% · Vol (1Y) 74.4% Price2023-08-21 → 2026-08-19 TNXP close: $3,021 on 2023-08-21 to $13 on 2026-08-19. Split-adj closes · 240 of 3,425 · price returnⓘ At a glance | Short interest21.0% of sh out | | Days to cover7.2d | | 13F net flow (QoQ)+1.39% | | Top-10 13F concentration79.6% | | Next report (est.)2026-11-09 |
SI 2026-07-31 · 13F 2026-Q1ⓘ Key fundamentalsFY 2025 | Sales (TTM)$29.1M | | Earnings (TTM)-$159.7M | | ROE−64.5% | | Net margin−946.2% |
FY ratios · TTM sales/earnings (USD)ⓘ Trailing returns | YTD−18.5% | | 1Y−65.2% | | 3Y−99.6% | | 5Y−100.0% | | 10Y−100.0% | | Since incept. (ann.)−77.2% |
Price return · from 2012-05-10ⓘ Risk | Ann. volatility (1Y)74.4% | | Ann. volatility (3Y)151.8% | | Sharpe (1Y)−1.18 | | Sharpe (3Y)−0.46 | | Max drawdown (1Y)−76.3% | | Max drawdown (3Y)−99.8% | | Beta (3Y vs SPY)−0.84 |
Daily returns, ann.ⓘ Top institutional holders13F 2026-Q1 | Manager | Shares | Value | % sh out | QoQ |
|---|
| BlackRock, Inc. | 968,177 | $13M | 7.22% | +9.4% | | VANGUARD CAPITAL MANAGEMENT LLC | 518,650 | $7M | 3.87% | new | | CITADEL ADVISORS LLC | 468,712 | $6M | 3.50% | new | | Jones Hill Capital LP | 452,116 | $6M | 3.37% | new | | GEODE CAPITAL MANAGEMENT, LLC | 313,291 | $4M | 2.34% | +15.2% | | Balyasny Asset Management L.P. | 313,082 | $4M | 2.34% | +68.9% | | UBS Group AG | 231,678 | $3M | 1.73% | +153.3% | | STATE STREET CORP | 230,607 | $3M | 1.72% | +20.2% |
Δ vs 2025-Q4ⓘ Latest reported quarterslast report 2026-08-10 | Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|
| 2026-06-30 | 2026-08-10 | −$2.44 | — | $13.5M | +577.9% | | 2026-03-31 | 2026-05-11 | −$2.93 | — | $6.9M | +183.2% | | 2025-12-31 | 2026-02-03 | — | — | $5.4M | +108.8% | | 2025-09-30 | 2025-11-10 | −$3.59 | — | $3.3M | +16.6% |
As-reported XBRL · next 2026-11-09 est.ⓘ Segment mixFY2025 (ended Dec 2025) Zembrace Symtouch 71% · Tosymra 18% · Tonmya 11% product & service · TAGGED revenueⓘ Basis & disclosures - EOD closes · nothing imputed or averaged · absent “—”
- As-of differs by block · 13F = US long, 45+d lag, LOWER bound
- Not investment advice · no recommendation, price target or solicitation
- EDGAR + foreign registers · marketstack (licensed EOD) · spzco.com/methodology
|
